Quantcast

PharMEDium Announces Propofol, Ready-to-Use, Single Patient, Syringe Service for Operating Room Anesthesia

December 20, 2010

LAKE FOREST, Ill., Dec. 20, 2010 /PRNewswire/ — PharMEDium Services LLC, announced the addition of Propofol to its custom operating room anesthesia syringe preparation services. PharMEDium is the first compounder to offer Propofol in a pre-labeled, single patient, ready-to-use, tamper evident syringe admixture system. Healthcare organizations recognize benefits of PharMEDium’s prefilled operating room syringes including compliance with regulatory requirements for proper labeling of all medications, and improved economic efficiency by reducing waste.

PharMEDium’s offering will fulfill an unmet need for customers assuring just-in-time, pre-labeled and ready-to-use Propofol in a syringe form. Propofol is used in inpatient and outpatient surgical procedures to induce anesthesia prior to the administration of an inhaled general anesthetic or as the primary anesthetic for total intravenous anesthesia (TIVA). It is also used in procedures outside the operating room for sedation and anesthesia. PharMEDium’s service eliminates provider-prepared syringe drawn up in a non-sterile environment and reduces waste with the use of less than the full vial amount when a smaller dose is needed.

PharMEDium is the national leading provider of pharmacy sterile intravenous admixture compounding services. The PharMEDium network of state licensed and federally registered compounding facilities provides trusted solutions to hospitals throughout the United States. PharMEDium complies with all applicable state laws and FDA regulations, including USP Chapter (797), and DEA requirements. For more information on PharMEDium, visit www.pharmedium.com.

SOURCE PharMEDium Services LLC


Source: newswire



comments powered by Disqus